UCVA's 3rd Annual Cardiovascular Conference

This years CME event was held at the Monroe Golf Club.  We would like to thank all of those who attended; we look forward to seeing each of you again next year!  For those of you who were unable to attend, please feel free to download the presentation slides and submit any questions via the General Questions form.  We have reviewed all of the evaluation forms and appreciate everyone's feedback and topic suggestions.  This information will aid in the continued success of our annual event.  We have also posted the answers to any questions that were left on these forms; please click the questions below to view the answer.   

Presentation Slides

Stress Testing for CAD:  What is the best choice for your patient.  David R. Fries, MD, FACC

ACE inhibitor & ARB use in patients with CHF and renal insufficiency.  John D. Bisognano, MD, PhD

Valvular Surgery in the Elderly.  Peter A. Knight, MD

Common Adult Congenital Heart Defects.  Peter A. Kringstein, MD, FACC

Diabetes Mellitus, How Low Should You Go.  K.K. Rajamani, MD 

New Frontiers in Anti-thrombotic Therapy for Atrial Fibrillation.  Abrar H. Shah, MD, FACC

Questions and Answers

What are the options of different Nuclear Stress Testing, and why would you choose one over the other?

For what duration should Plavix be used after a stent?

Should BMP be checked at baseline before starting ACE-I, ARB?

Unsure of Post-pacing EKG changes (the complexes which follow paced beats), can you clarify?

Who would you put on pradaxa and who would you still use Coumadin on?

I am still uncomfortable with Dabigatran (Pradaxa) due to no antidote, esp. in young patients- (pregnancy/more high risk behaviors).  What  guidelines can you suggest in choosing the most appropriate agent to use?

If you have any further questions, please do not hesitate to submit them via our General Questions form.